How does volume affect Wells Pharmacy Network pricing?

Before scaling a program with Wells Pharmacy Network, work through these questions in writing. Does per-Rx cost change at volume thresholds for your key formulations — semaglutide, tirzepatide, testosterone, or your highest-volume peptide? If so, what are the thresholds and what is the per-Rx cost at each level? Is the rate fixed once confirmed or does it renegotiate at intervals? What happens if your volume drops below a threshold — does cost step back up, and by how much? And do better rates require a minimum order commitment or a contract term?

Getting those answers in writing before you build patient pricing is the difference between a volume program built on confirmed economics and one built on an assumption you will verify later. The post-order pricing visibility model in WellsPx3 means you will always see what each order cost — but you will see it after the prescription is already placed. For a high-volume GLP-1 refill day, that is a meaningful timing gap if the per-vial cost comes back higher than your margin model assumed.

Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment, whether you are a new clinic or a high-volume practice. There is no volume gate before the cost is visible — you see the number during evaluation, on your first day of access, before you commit to anything.

For clinics still scaling, that removes the chicken-and-egg problem: you do not need volume to see cost, and you do not need to commit to scale before you know what it costs. You can compare a visible per-vial number against any Wells Pharmacy Network estimate on the exact SKUs you order most, and decide based on confirmed landed cost rather than a volume promise whose terms you have not yet seen in writing.